Back to Search
Start Over
Astellas Pharma Global Development Inc. Researcher Details Findings in Opioids (A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder)
- Source :
- Obesity, Fitness & Wellness Week. February 25, 2023, 72
- Publication Year :
- 2023
-
Abstract
- 2023 FEB 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on opioids are presented in a new report. According to [...]
- Subjects :
- Pharmacokinetics -- Analysis
Drug interactions -- Analysis
Health
Subjects
Details
- Language :
- English
- ISSN :
- 15316386
- Database :
- Gale General OneFile
- Journal :
- Obesity, Fitness & Wellness Week
- Publication Type :
- Periodical
- Accession number :
- edsgcl.737826170